Novartis AG Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

11:29 EDT 2 Oct 2018 | BioPortfolio Reports

Novartis AG Strategy, SWOT and Corporate Finance Report


Novartis AG Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Novartis AG Novartis or the company' is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is involved in the research, development, manufacture and marketing of medicines, eye care products and generic pharmaceuticals. In addition, it offers these products to treat cancer, cardiovascular, dermatological, neurological, ophthalmic, respiratory and infectious diseases, and immune disorders.It also conducts various research and development activities through its Novartis Institutes for BioMedical Research NIBR. Novartis is headquartered in Basel, Switzerland.


Detailed information on Novartis AG required for business and competitor intelligence needs

A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis

An indepth view of the business model of Novartis AG including a breakdown and examination of key business segments

Intelligence on Novartis AG's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Novartis AG, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Novartis AG and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Novartis AG as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Novartis AG's business structure, strategy and prospects.

Original Article: Novartis AG Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175


More From BioPortfolio on "Novartis AG Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...